Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Wore a $7 kids' shirt
Diagnosed with autism
Missouri doctor found
Baby via surrogate
Manson follower parole
Chris Klein fired
Missing, found dead
Won’t recast Miller
Disagrees with Dodgers
Headed for contempt
Arrested over rapes
Driver duct taped boy?
Talks mental health
AI ignites controversy
4th child at 83
Return from space
Fertility doctor fraud
JP $26B for childcare
Reade defects to RU
107M-year-old bones
Manhattanhenge
Chief retires in June
Fla. fentanyl busts up
Dinosaur exhibit shut
To recruit new pres
Toyota data leak risk
Carbon neutrality suit
Smoke-free Sweden
Robbery turns deadly
2024 presidential run
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
14,600 results
8don MSN
FDA approves prescription nasal spray to reverse opioid overdoses
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...
WTVF29d
FDA approves first over-the-counter naloxone nasal spray
NASHVILLE, Tenn. (WTVF) — The FDA recently approved an over-the-counter naloxone nasal spray. The medication, known as Narcan, reverses the effects of an opioid overdose. Advocates say it's a ...
Yahoo News8d
US FDA approves Opiant's spray for reversing opioid-related overdoses
The approval comes nearly two months after the U.S. health regulator approved the prescription-free sale of Emergent Biosolutions' Narcan nasal spray, which is a naloxone-based drug used to reverse ...
drugdeliverybusiness8d
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
Medscape5d
FDA Approvals
FDA Approves Methylphenidate Patch for Teens With ADHD The FDA has approved an expanded age range for a methylphenidate transdermal system for the treatment of ADHD in adolescents aged 13 to 17 years.
Seeking Alpha20d
Emergent BioSolutions: A Turnaround In Sight With OTC Narcan Amidst Ongoing Opioid Crisis
The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses. OTC Narcan can contribute significantly to combatting the escalating opioid crisis in the U.S. The OTC ...
AOL7d
Here's why parents should have Narcan, the drug that reverses an opioid overdose, at home: 'This is a lifesaving medication'
In an effort to reduce the rising number of opioid overdoses in the U.S., including from fentanyl, the Food and Drug Administration (FDA) in March approved the first over-the-counter Narcan nasal ...
8d
FDA Approves New Nasal Spray to Reverse Opioid Overdoses
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
FOX 10 Phoenix
8d
FDA approves new nasal spray to reverse fentanyl, other opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
Too Old to Operate
7d
FDA Approves New Nasal Spray to Reverse Overdoses
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will ...
EMS1
8d
FDA approves new nasal spray to reverse fentanyl, opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
High Times
7d
FDA Approves Nasal Spray To Reverse Fentanyl Overdoses
The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback